#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Homocystinuria Pleural mesothelioma malignant Cystic fibrosis Arteriosclerosis B-cell lymphoma recurrent Endocrine ophthalmopathy Bile acid synthesis disorder Atopic keratoconjunctivitis Hereditary ataxia Polyneuropathy Myocarditis Hepatoblastoma Orthostatic hypotension Arterial disorder Oropharyngeal squamous cell carcinoma More trials…

    Learn about Rare Diseases

    Lymphangioma – Trials in Disease Splenic marginal zone lymphoma – Treatment Leukoencephalopathy – Basic Information Primary mediastinal large B-cell lymphoma – Basic Information Short-bowel syndrome Antithrombin III deficiency – Basic Information Primary hyperoxaluria Chondrosarcoma metastatic – Basic Information X-linked lymphoproliferative syndrome Primary hyperoxaluria – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSKVX000000048111 Bi 765845 Emraclidine Heparin Tovorafenib M1P Dipotassium Salt Interferon Beta-1B Betula Alba Pollen Extract Etuvetidigene Autotemcel Lucerastat Cl-Ad-Msc-002 GUAIACOL Pevonedistat Alkaline Phosphatase, Bovine SELTOREXANT Venetoclax Cls12311 Methoxsalen Jab-21822 RNK001 More therapies…

    Learn about Your Condition

    Breast conserving surgery Multiple sclerosis Mucopolysaccharidosis III Drug dependence Cortisol abnormal Follicular lymphoma Hyponatraemia Epidermolysis bullosa Mitral valve disease Heart transplant Albright's disease Diabetic ketoacidosis Cachexia Myxoid liposarcoma Urea cycle disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Efficacy of efanesoctocog alfa in reducing synovitis in patients with congenital hemophilia A – a multicenter, randomized, open‑label phase 3 trial

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Synovitis
    • Factor VIII deficiency
    Investigated Drugs:
    • Efanesoctocog Alfa
    Austria Germany

  • Study of denikitug alone or in drug combination in adults with advanced microsatellite stable colorectal cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Tipiracil Hydrochloride
    • Trifluridine
    • Bevacizumab
    France Italy Spain

  • Evaluation of FG001 imaging agent in patients with oropharyngeal and oral squamous cell carcinoma undergoing transoral robotic surgery or neck dissection

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • FG001
    Denmark

  • Phase IIb Randomized, Double‑Blind Study of GIA632 in Adults with Nonsegmental Vitiligo

    Not yet recruiting

    2 1
    France Germany Italy The Netherlands Spain

  • Oral corticosteroid tapering with ravulizumab, prednisone and prednisolone in adult patients with generalized myasthenia gravis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    Investigated Drugs:
    • Ravulizumab
    • Prednisolone
    • Prednisone
    Germany Italy

  • Cannabidiol for Alcohol Dependence in Adults Seeking Abstinence: A Phase II Placebo‑Controlled Trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Alcohol abuse
    Investigated Drugs:
    • CANNABINOL
    Spain
Previous Page
1 … 698 699 700 701 702 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!